AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 124 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $341,000 | -23.5% | 45,517 | -7.2% | 0.00% | 0.0% |
Q1 2022 | $446,000 | +44500.0% | 49,031 | +70959.4% | 0.00% | – |
Q2 2021 | $1,000 | -97.6% | 69 | -95.9% | 0.00% | – |
Q4 2015 | $41,000 | +57.7% | 1,689 | +14.4% | 0.00% | – |
Q2 2015 | $26,000 | -89.8% | 1,477 | -81.8% | 0.00% | -100.0% |
Q1 2015 | $255,000 | – | 8,125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 244,783 | $1,718,000 | 0.77% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $32,959,000 | 0.69% |
DCF Advisers, LLC | 192,065 | $1,348,000 | 0.55% |
LEVIN CAPITAL STRATEGIES, L.P. | 817,377 | $5,738,000 | 0.54% |
DAFNA Capital Management LLC | 289,040 | $2,029,000 | 0.51% |
Rhenman & Partners Asset Management AB | 750,000 | $5,378,000 | 0.36% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,175,000 | 0.31% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,203,592 | $8,449,000 | 0.30% |
AlphaCentric Advisors LLC | 137,000 | $962,000 | 0.28% |
PFM Health Sciences, LP | 1,088,566 | $7,642,000 | 0.26% |